Connection
Talia Quandelacy to Humans
This is a "connection" page, showing publications Talia Quandelacy has written about Humans.
|
|
Connection Strength |
|
 |
|
 |
|
0.180 |
|
|
|
-
Quandelacy TM, Hitchings MDT, Lessler J, Read JM, Vukotich C, Azman AS, Salje H, Zimmer S, Gao H, Zheteyeva Y, Uzicanin A, Cummings DAT. Household Transmission Dynamics of Seasonal Human Coronaviruses. J Infect Dis. 2023 04 26; 227(9):1104-1112.
Score: 0.024
-
Quandelacy TM, Adams LE, Munoz J, Santiago GA, Kada S, Johansson MA, Alvarado LI, Rivera-Amill V, Paz-Bailey G. Reduced spread of influenza and other respiratory viral infections during the COVID-19 pandemic in southern Puerto Rico. PLoS One. 2022; 17(4):e0266095.
Score: 0.022
-
Quandelacy TM, Zimmer S, Lessler J, Vukotich C, Bieltz R, Grantz KH, Galloway D, Read JM, Zheteyeva Y, Gao H, Uzicanin A, Cummings DAT. Predicting virologically confirmed influenza using school absences in Allegheny County, Pennsylvania, USA during the 2007-2015 influenza seasons. Influenza Other Respir Viruses. 2021 11; 15(6):757-766.
Score: 0.021
-
Quandelacy TM, Healy JM, Greening B, Rodriguez DM, Chung KW, Kuehnert MJ, Biggerstaff BJ, Dirlikov E, Mier-Y-Teran-Romero L, Sharp TM, Waterman S, Johansson MA. Estimating incidence of infection from diverse data sources: Zika virus in Puerto Rico, 2016. PLoS Comput Biol. 2021 03; 17(3):e1008812.
Score: 0.021
-
Quandelacy TM, Cummings DAT, Jiang CQ, Yang B, Kwok KO, Dai B, Shen R, Read JM, Zhu H, Guan Y, Riley S, Lessler J. Using serological measures to estimate influenza incidence in the presence of secular trends in exposure and immuno-modulation of antibody response. Influenza Other Respir Viruses. 2021 03; 15(2):235-244.
Score: 0.020
-
Quandelacy TM, Viboud C, Charu V, Lipsitch M, Goldstein E. Age- and sex-related risk factors for influenza-associated mortality in the United States between 1997-2007. Am J Epidemiol. 2014 Jan 15; 179(2):156-67.
Score: 0.012
-
Quandelacy TM, Johns MC, Andraghetti R, Hora R, Meynard JB, Montgomery JM, Roque VG, Blazes DL. The role of disease surveillance in achieving IHR compliance by 2012. Biosecur Bioterror. 2011 Dec; 9(4):408-12.
Score: 0.011
-
Garc?a-Carreras B, Hitchings MDT, Johansson MA, Biggerstaff M, Slayton RB, Healy JM, Lessler J, Quandelacy T, Salje H, Huang AT, Cummings DAT. Accounting for assay performance when estimating the temporal dynamics in SARS-CoV-2 seroprevalence in the U.S. Nat Commun. 2023 04 19; 14(1):2235.
Score: 0.006
-
Pluss O, Campbell H, Pezzi L, Morales I, Roell Y, Quandelacy TM, Arora RK, Boucher E, Lamb MM, Chu M, B?rnighausen T, Jaenisch T. Limitations introduced by a low participation rate of SARS-CoV-2 seroprevalence data. Int J Epidemiol. 2023 02 08; 52(1):32-43.
Score: 0.006
-
Pollett S, Johansson MA, Reich NG, Brett-Major D, Del Valle SY, Venkatramanan S, Lowe R, Porco T, Berry IM, Deshpande A, Kraemer MUG, Blazes DL, Pan-Ngum W, Vespigiani A, Mate SE, Silal SP, Kandula S, Sippy R, Quandelacy TM, Morgan JJ, Ball J, Morton LC, Althouse BM, Pavlin J, van Panhuis W, Riley S, Biggerstaff M, Viboud C, Brady O, Rivers C. Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines. PLoS Med. 2021 10; 18(10):e1003793.
Score: 0.005
-
S?nchez-Gonz?lez L, Quandelacy TM, Johansson M, Torres-Vel?squez B, Lorenzi O, Tavarez M, Torres S, Alvarado LI, Paz-Bailey G. Viral etiology and seasonal trends of pediatric acute febrile illness in southern Puerto Rico; a seven-year review. PLoS One. 2021; 16(2):e0247481.
Score: 0.005
-
Johansson MA, Quandelacy TM, Kada S, Prasad PV, Steele M, Brooks JT, Slayton RB, Biggerstaff M, Butler JC. SARS-CoV-2 Transmission From People Without COVID-19 Symptoms. JAMA Netw Open. 2021 01 04; 4(1):e2035057.
Score: 0.005
-
Sharp TM, Quandelacy TM, Adams LE, Aponte JT, Lozier MJ, Ryff K, Flores M, Rivera A, Santiago GA, Mu?oz-Jord?n JL, Alvarado LI, Rivera-Amill V, Garcia-Negr?n M, Waterman SH, Paz-Bailey G, Johansson MA, Rivera-Garcia B. Epidemiologic and spatiotemporal trends of Zika Virus disease during the 2016 epidemic in Puerto Rico. PLoS Negl Trop Dis. 2020 09; 14(9):e0008532.
Score: 0.005
-
Biggerstaff M, Cowling BJ, Cucunub? ZM, Dinh L, Ferguson NM, Gao H, Hill V, Imai N, Johansson MA, Kada S, Morgan O, Pastore Y Piontti A, Polonsky JA, Prasad PV, Quandelacy TM, Rambaut A, Tappero JW, Vandemaele KA, Vespignani A, Warmbrod KL, Wong JY. Early Insights from Statistical and Mathematical Modeling of Key Epidemiologic Parameters of COVID-19. Emerg Infect Dis. 2020 11; 26(11):e1-e14.
Score: 0.005
-
Paz-Bailey G, Quandelacy TM, Adams LE, Olsen SJ, Blanton L, Munoz-Jordan JL, Lozier M, Alvarado LI, Johansson MA. Recent influenza activity in tropical Puerto Rico has become synchronized with mainland US. Influenza Other Respir Viruses. 2020 09; 14(5):515-523.
Score: 0.005
-
Kobres PY, Chretien JP, Johansson MA, Morgan JJ, Whung PY, Mukundan H, Del Valle SY, Forshey BM, Quandelacy TM, Biggerstaff M, Viboud C, Pollett S. A systematic review and evaluation of Zika virus forecasting and prediction research during a public health emergency of international concern. PLoS Negl Trop Dis. 2019 10; 13(10):e0007451.
Score: 0.005
-
Fukuda MM, Klein TA, Kochel T, Quandelacy TM, Smith BL, Villinski J, Bethell D, Tyner S, Se Y, Lon C, Saunders D, Johnson J, Wagar E, Walsh D, Kasper M, Sanchez JL, Witt CJ, Cheng Q, Waters N, Shrestha SK, Pavlin JA, Lescano AG, Graf PC, Richardson JH, Durand S, Rogers WO, Blazes DL, Russell KL, Akala H, Gaydos JC, DeFraites RF, Gosi P, Timmermans A, Yasuda C, Brice G, Eyase F, Kronmann K, Sebeny P, Gibbons R, Jarman R, Waitumbi J, Schnabel D, Richards A, Shanks D. Malaria and other vector-borne infection surveillance in the U.S. Department of Defense Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance program: review of 2009 accomplishments. BMC Public Health. 2011 Mar 04; 11 Suppl 2:S9.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|